Acadia Healthcare (NASDAQ:ACHC) Price Target Lowered to $66.00 at TD Cowen

Acadia Healthcare (NASDAQ:ACHC) had its price objective dropped by equities researchers at TD Cowen from $70.00 to $66.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. TD Cowen’s target price would suggest a potential upside of 46.28% from the company’s previous close.

Several other equities analysts have also commented on ACHC. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $52.00 target price on shares of Acadia Healthcare in a report on Tuesday, December 10th. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and increased their target price for the company from $45.00 to $75.00 in a report on Thursday, December 12th. StockNews.com lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday. Royal Bank of Canada reduced their target price on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a report on Monday, November 18th. Finally, Barclays dropped their price target on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research report on Friday, November 22nd. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, Acadia Healthcare has an average rating of “Moderate Buy” and a consensus price target of $70.22.

Acadia Healthcare Price Performance

Shares of NASDAQ:ACHC opened at $45.12 on Tuesday. The company’s fifty day moving average price is $40.43 and its 200-day moving average price is $58.28. The firm has a market capitalization of $4.19 billion, a price-to-earnings ratio of 14.79, a PEG ratio of 1.77 and a beta of 1.29. Acadia Healthcare has a one year low of $36.50 and a one year high of $87.77. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The company had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. During the same quarter last year, the firm earned $0.91 EPS. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. On average, equities research analysts anticipate that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Acadia Healthcare

Several institutional investors and hedge funds have recently modified their holdings of the stock. Wellington Management Group LLP lifted its position in shares of Acadia Healthcare by 12.2% in the 3rd quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock worth $739,250,000 after purchasing an additional 1,266,384 shares during the period. William Blair Investment Management LLC lifted its position in shares of Acadia Healthcare by 20.7% in the 2nd quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock worth $237,434,000 after purchasing an additional 604,070 shares during the period. JPMorgan Chase & Co. lifted its position in shares of Acadia Healthcare by 17.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock worth $198,258,000 after purchasing an additional 454,044 shares during the period. State Street Corp lifted its position in shares of Acadia Healthcare by 3.5% in the 3rd quarter. State Street Corp now owns 2,819,911 shares of the company’s stock worth $178,811,000 after purchasing an additional 95,613 shares during the period. Finally, Point72 Asset Management L.P. lifted its position in shares of Acadia Healthcare by 0.5% in the 3rd quarter. Point72 Asset Management L.P. now owns 2,282,810 shares of the company’s stock worth $144,753,000 after purchasing an additional 12,470 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.